Web Analytics
CRBU (NASDAQ) 株価分析 | CARIBOU BIOSCIENCES INC – Deepscope
MARKET

Select Market Data Region

CRBU 株価分析 — Caribou Biosciences Inc (Healthcare >> Biotechnology)

CRBU に関するよくある質問

CRBUのROE(自己資本利益率)は?

Caribou Biosciences IncのROEは-130.58%です。

CRBUの配当利回りは?

Caribou Biosciences Incの配当利回りは0.00%です。

CRBUの品質スコア(Quality Score)は?

当社のAIはCRBUの総合財務品質を100点中23点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

CRBUは今が買い時ですか?

当社AIのタイミングスコアは100点中27点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

CRBUはどのセクターに属しますか?

Caribou Biosciences IncはHealthcare >> Biotechnologyセクターに分類されます(NASDAQ市場)

Stock Check   *Daily update data at 8:30 AM*
(Price: 2026-08-04 | FS: 2026-03-31)

CRBU AI Analysis Summary

Our AI summary for CRBU: Caribou Biosciences Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -130.58%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

CRBU

Caribou Biosciences Inc
USD 1.57
0.07 (4.67%) Day Change
0.01
D/E
-130.6%
ROE
-89.4%
ROA
0.00%
Div Yield
USD 1.57
Price
0.07 (4.67%)
Day Change
NEWS SCORE: 98

CRBU, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) そして テクニカルスコアは ...(Sign In to See)...

23

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Momentum indicators aligned on the daily timeframe
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析 47%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 98
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 1.57
  PBV / Sector
1.46 / 44,022.72
GOOD
  Earning Per Share -1.41
  PE / Sector
N/A / 19.17
  PEG or PE/Growth / Sector
N/A / 1.24
  Average 1M Daily Value
2.94 M
GREAT
  Average 1W Daily Value
1.83 M
GREAT
Timing Factors 42%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Financial Health 45%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
ポイントになる統計 56%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
-1,189.14 / 98.24
  NPM Average (%) / Sector
-1,004.47 / -1,697.63
  NPM Change Average (%) / Sector
80.94 / 5,097.97
GREAT
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-89.41 / 185,260.96
  ROA Average (%) / Sector
-54.34 / 36,684.70
  ROA Change Average (%) / Sector
43.41 / 422,221.66
GREAT
  ROE (%) / Sector
-130.58 / 243,762.23
  ROE Average (%) / Sector
-74.30 / 48,758.47
  ROE Change Average (%) / Sector
52.50 / 424,968.10
GREAT
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
配当 4%
X
  Dividend (%) / Sector
N/A / 0.04
  Dividend Average (%) / Sector
N/A / 17.04
  Dividend Change Average (%) / Sector
N/A / -0.49
登録情報
X
  Analyze Date 2026-08-05 08:00:01
  Symbol CRBU
  Name CARIBOU BIOSCIENCES INC
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 99.18 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 148.77 / 9,586.08
ニュース
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 2929 7th Street, Berkeley, CA, United States, 94710

Phone: 510 982 6030

Website: https://cariboubio.com

Employees: 97

Sector: Healthcare >> Biotechnology

Description: Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.

Analyst Ratings & Target Price

3 Months Ago
1 Month Ago
Current
Strong Buy
5
5
5
Buy
2
2
2
Hold
2
2
2
Sell
0
0
0
Strong Sell
0
0
0
Consensus
Buy 4.33
Buy 4.33
Buy 4.33
Target Price
USD 11.71
USD 12.00
USD 12.00

Per-Share Earnings, Estimates vs Actuals

Actual
Analyst Range
Estimate

ME vs SECTOR Healthcare >> Biotechnology

CRBU (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

同業種の銘柄

Healthcare › Biotechnology

同じ基準で分析・時価総額順

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
CRBU
CRBU
USD 1.57 (4.67%)
+ Watch + Port Chart